Clinical Trial Update: Phase I Study of XTL6001 Injection in Healthy and Obese Subjects [Phase 1]

View source ↗

Summary

Phase I study update for XTL6001 Injection in healthy and obese adults evaluating weight management. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• XTL6001

Snippet

Sponsor: Shanghai Xitaili Biomedicine Technology co., Ltd. | Conditions: Weight Management in Adult Patients With Obesity or Overweight | Phase 1 | Status: RECRUITING